skip to main content

Title: Follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma

A new radiopharmaceutical, I-131 metaiodobenzylguanidine (I-131 MIBG) was used to determine the location and to follow-up tumors in a 13-month-old girl with neuroblastoma. I-131 MIBG imaging revealed both a primary abdominal tumor and a distant metastatic orbital tumor. Follow-up study with I-131 MIBG imaging demonstrated significant resolution of tumors after external radiotherapy and chemotherapy. I-131 MIBG imaging is a simple, safe, and specific method of determining the location of tumors and also is clinically useful in the evaluation and management of patients with neuroblastoma.
Authors:
; ; ; ; ; ; ;
Publication Date:
OSTI Identifier:
6796487
Resource Type:
Journal Article
Resource Relation:
Journal Name: Clin. Nucl. Med.; (United States); Journal Volume: 11
Research Org:
Kobe General Hospital, Japan
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; ABDOMEN; NEOPLASMS; RADIOISOTOPE SCANNING; DIAGNOSIS; IODINE 131; METASTASES; PATIENTS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; BODY AREAS; COUNTING TECHNIQUES; DAYS LIVING RADIOISOTOPES; DISEASES; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; NUCLEI; ODD-EVEN NUCLEI; RADIOISOTOPES 550601* -- Medicine-- Unsealed Radionuclides in Diagnostics